270 related articles for article (PubMed ID: 30213070)
21. Methods for Evaluating Right Ventricular Function and Ventricular-Arterial Coupling.
Kubba S; Davila CD; Forfia PR
Prog Cardiovasc Dis; 2016; 59(1):42-51. PubMed ID: 27393072
[TBL] [Abstract][Full Text] [Related]
22. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
[TBL] [Abstract][Full Text] [Related]
23. Stage‑dependent changes of β2‑adrenergic receptor signaling in right ventricular remodeling in monocrotaline‑induced pulmonary arterial hypertension.
Sun F; Lu Z; Zhang Y; Geng S; Xu M; Xu L; Huang Y; Zhuang P; Zhang Y
Int J Mol Med; 2018 May; 41(5):2493-2504. PubMed ID: 29393391
[TBL] [Abstract][Full Text] [Related]
24. RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis
Banerjee S; Onwunyi VRC; Hong J; Martineau S; Fishbein GA; Bonnet SB; Provencher S; Bonnet S; Umar S
bioRxiv; 2024 May; ():. PubMed ID: 38746200
[TBL] [Abstract][Full Text] [Related]
25. PPARγ Alleviates Right Ventricular Failure Secondary to Pulmonary Arterial Hypertension in Rats.
Xu Y; Gu Q; Liu N; Yan Y; Yang X; Hao Y; Qu C
Int Heart J; 2017 Dec; 58(6):948-956. PubMed ID: 29151490
[TBL] [Abstract][Full Text] [Related]
26. Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
Kaur G; Singh N; Lingeshwar P; Siddiqui HH; Hanif K
Pulm Pharmacol Ther; 2015 Feb; 30():66-79. PubMed ID: 25481773
[TBL] [Abstract][Full Text] [Related]
27. Tricuspid regurgitation duration correlates with cardiovascular magnetic resonance-derived right ventricular ejection fraction and predict prognosis in patients with pulmonary arterial hypertension.
Cho IJ; Oh J; Chang HJ; Park J; Kang KW; Kim YJ; Choi BW; Shin S; Shim CY; Hong GR; Ha JW; Chung N
Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):18-23. PubMed ID: 23704751
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous ventricular fibrillation in right ventricular failure secondary to chronic pulmonary hypertension.
Umar S; Lee JH; de Lange E; Iorga A; Partow-Navid R; Bapat A; van der Laarse A; Saggar R; Saggar R; Ypey DL; Karagueuzian HS; Eghbali M
Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):181-90. PubMed ID: 22199010
[TBL] [Abstract][Full Text] [Related]
29. The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease.
Comarița IK; Tanko G; Anghelache IL; Georgescu A
J Transl Med; 2024 Feb; 22(1):137. PubMed ID: 38317144
[TBL] [Abstract][Full Text] [Related]
30. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
31. Multi-omic and multispecies analysis of right ventricular dysfunction.
Mendelson JB; Sternbach JD; Doyle MJ; Mills L; Hartweck LM; Tollison W; Carney JP; Lahti MT; Bianco RW; Kalra R; Kazmirczak F; Hindmarch C; Archer SL; Prins KW; Martin CM
J Heart Lung Transplant; 2024 Feb; 43(2):303-313. PubMed ID: 37783299
[TBL] [Abstract][Full Text] [Related]
32. Right ventricular electrical remodeling and arrhythmogenic substrate in rat pulmonary hypertension.
Tanaka Y; Takase B; Yao T; Ishihara M
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):426-36. PubMed ID: 23600532
[TBL] [Abstract][Full Text] [Related]
33. Salubrinal attenuates right ventricular hypertrophy and dysfunction in hypoxic pulmonary hypertension of rats.
He YY; Liu CL; Li X; Li RJ; Wang LL; He KL
Vascul Pharmacol; 2016 Dec; 87():190-198. PubMed ID: 27678416
[TBL] [Abstract][Full Text] [Related]
34. Defining the molecular signatures of human right heart failure.
Williams JL; Cavus O; Loccoh EC; Adelman S; Daugherty JC; Smith SA; Canan B; Janssen PML; Koenig S; Kline CF; Mohler PJ; Bradley EA
Life Sci; 2018 Mar; 196():118-126. PubMed ID: 29366750
[TBL] [Abstract][Full Text] [Related]
35. Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats.
Yin J; You S; Li N; Jiao S; Hu H; Xue M; Wang Y; Cheng W; Liu J; Xu M; Yan S; Li X
Respir Res; 2016 Aug; 17(1):99. PubMed ID: 27491388
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
Potus F; Ruffenach G; Dahou A; Thebault C; Breuils-Bonnet S; Tremblay È; Nadeau V; Paradis R; Graydon C; Wong R; Johnson I; Paulin R; Lajoie AC; Perron J; Charbonneau E; Joubert P; Pibarot P; Michelakis ED; Provencher S; Bonnet S
Circulation; 2015 Sep; 132(10):932-43. PubMed ID: 26162916
[TBL] [Abstract][Full Text] [Related]
37. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.
Bogaard HJ; Natarajan R; Mizuno S; Abbate A; Chang PJ; Chau VQ; Hoke NN; Kraskauskas D; Kasper M; Salloum FN; Voelkel NF
Am J Respir Crit Care Med; 2010 Sep; 182(5):652-60. PubMed ID: 20508210
[TBL] [Abstract][Full Text] [Related]
38. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure.
Banerjee S; Hong J; Umar S
Front Cardiovasc Med; 2022; 9():935423. PubMed ID: 36158812
[TBL] [Abstract][Full Text] [Related]
40. Systolic right ventricular function in children and young adults with pulmonary artery hypertension secondary to congenital heart disease and tetralogy of Fallot: tricuspid annular plane systolic excursion (TAPSE) and magnetic resonance imaging data.
Koestenberger M; Nagel B; Avian A; Ravekes W; Sorantin E; Cvirn G; Beran E; Halb V; Gamillscheg A
Congenit Heart Dis; 2012; 7(3):250-8. PubMed ID: 22494699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
